KARACHI: The Sindh High Court (SHC) on Thursday directed the federal government to decide the price of Panadol, a medicine that is used for relieving fever and pain, in the next four weeks.
The SHC issued the orders after hearing a contempt of court petition filed by the pharmaceutical company. The manufacturer had moved the SHC after the government set aside the court’s earlier orders about raising the price of Panadol.
During the course of the proceedings, the officials of the Drug Regulatory Authority of Pakistan (Drap) apprised the court that the federal government’s node is needed to raise the price of medicines.
At this, the SHC directed the federal government to decide the price of the medicine in the next cabinet meeting and submit a report to the court in this regard.
The Centre’s lawyer admitted that the matter related to the price of Panadol did not come under discussion in the previous cabinet meeting.
In its petition, the pharmaceutical company stated that they purchase raw materials for the medicine in dollars, adding that the cost of the medicine has increased significantly due to the rupee’s continuous fall against the greenback in recent weeks.
The petitioner said that the government is reluctant to increase the price of the medicine.
This is the fifth poliovirus case from the province in 2024, while one has been reported from Sindh
Diet may not be only good for gut but likely to benefit cognition, motor ability, blood sugar levels
Sunscreen is considered much-needed skin care ritual by many people across globe, however, it may not be essential
"New service to ensure swift medical assistance for critical cases on motorways," says Khawaja Salman Rafique
Chinese researchers propose that gut microbiome is significant aspect to find out people's age
More than 7,400 deaths every day across Europe’s 53 states are caused by tobacco, fossil fuels, UPFs, alcohol